{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:56:33Z","timestamp":1761735393360,"version":"build-2065373602"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Delivery Science and Technology"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1016\/s1773-2247(12)50006-7","type":"journal-article","created":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T15:19:41Z","timestamp":1420125581000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeted lipid-based systems for siRNA delivery"],"prefix":"10.1016","volume":"22","author":[{"given":"L.S.","family":"Mendon\u00e7a","sequence":"first","affiliation":[]},{"given":"M.C.","family":"Pedroso de Lima","sequence":"additional","affiliation":[]},{"given":"S.","family":"Sim\u00f5es","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1773-2247(12)50006-7_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/cbt.3.1.517","article-title":"Progress in the development of nucleic acid therapeutics for cancer","volume":"3","author":"Kalota","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2353\/ajpath.2007.070120","article-title":"Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies","volume":"171","author":"Bhindi","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.drudis.2008.03.014","article-title":"Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?","volume":"13","author":"Rayburn","year":"2008","journal-title":"Drug Discovery Today"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/b801920g","article-title":"Targeting transcription factors for therapeutic benefit","volume":"4","author":"Brennan","year":"2008","journal-title":"Mol. BioSyst."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/biot.200700215","article-title":"RNA interference: an emerging generation of biologicals","volume":"3","author":"Shrivastava","year":"2008","journal-title":"Biotechnol. J."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2007.03.009","article-title":"Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications","volume":"59","author":"Kumar","year":"2007","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0035","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1261\/rna.5103703","article-title":"siRNA function in RNAi: a chemical modification analysis","volume":"9","author":"Chiu","year":"2003","journal-title":"RNA"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.gt.3302703","article-title":"The silent treatment: siRNAs as small molecule drugs","volume":"13","author":"Dykxhoorn","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.bioeng.8.061505.095848","article-title":"Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs","volume":"8","author":"Dykxhoorn","year":"2006","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.genom.8.080706.092424","article-title":"Applications of RNA interference in mammalian systems","volume":"8","author":"Martin","year":"2007","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14728222.12.5.637","article-title":"Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications","volume":"12","author":"Huang","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejps.2005.12.002","article-title":"siRNA\u2013getting the message out","volume":"27","author":"Lee","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1677\/jme.1.01582","article-title":"RNA interference and the use of small interfering RNA to study gene function in mammalian systems","volume":"33","author":"Bantounas","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2133\/dmpk.22.142","article-title":"Targeted delivery systems of small interfering RNA by systemic administration","volume":"22","author":"Kawakami","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/path.1896","article-title":"Viral gene therapy strategies: from basic science to clinical application","volume":"208","author":"Young","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.bioeng.10.061807.160514","article-title":"Molecular engineering of viral gene delivery vehicles","volume":"10","author":"Schaffer","year":"2008","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/bit.21541","article-title":"Library selection and directed evolution approaches to engineering targeted viral vectors","volume":"98","author":"Jang","year":"2007","journal-title":"Biotechnol. Bioeng"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0090","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1208\/aapsj0901009","article-title":"Nonviral gene delivery: what we know and what is next","volume":"9","author":"Gao","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2478\/v10007-007-0021-9","article-title":"Physical mechanisms and methods employed in drug delivery to tumors","volume":"57","author":"Besic","year":"2007","journal-title":"Acta Pharm."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s11095-006-9233-9","article-title":"Cell and tissue targeting of nucleic acids for cancer gene therapy","volume":"24","author":"Russ","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biomaterials.2005.09.036","article-title":"Design of modular non-viral gene therapy vectors","volume":"27","author":"De Laporte","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jps.21024","article-title":"Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide","volume":"97","author":"Kawakami","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2003.09.013","article-title":"An overview of current delivery systems in cancer gene therapy","volume":"94","author":"El-Aneed","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00253-003-1321-8","article-title":"Non-viral gene therapy: polycation-mediated DNA delivery","volume":"62","author":"Thomas","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.10.028","article-title":"Biodegradable polymers as non-viral carriers for plasmid DNA delivery","volume":"126","author":"Luten","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-7799(98)01220-7","article-title":"Novel applications of liposomes","volume":"16","author":"Lasic","year":"1998","journal-title":"Trends Biotechnol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0145","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","volume":"97","author":"Drummond","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-409X(01)00110-7","article-title":"Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications","volume":"47","author":"Pedroso de Lima","year":"2001","journal-title":"Adv. Drug Delivery Rev"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0155","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.biomaterials.2008.04.036","article-title":"Progress in developing cationic vectors for non-viral systemic gene therapy against cancer","volume":"29","author":"Morille","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2004.08.019","article-title":"Cationic compounds used in lipoplexes and polyplexes for gene delivery","volume":"100","author":"Zhang","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0170","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/med.20090","article-title":"Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises","volume":"27","author":"Karmali","year":"2007","journal-title":"Med. Res. Rev."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425247.2.2.237","article-title":"Cationic liposomes for gene delivery","volume":"2","author":"Simoes","year":"2005","journal-title":"Expert Opin. Drug Delivery"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-5793(00)01558-1","article-title":"Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency","volume":"473","author":"Ghosh","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/bc010048h","article-title":"Advantage of the ether linkage between the positive charge and the cholesteryl skeleton in cholesterol-based amphiphiles as vectors for gene delivery","volume":"13","author":"Ghosh","year":"2002","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0190","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1021\/bi9801154","article-title":"A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity","volume":"37","author":"Aberle","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00232-002-1015-7","article-title":"On the mechanism of cationic amphiphile-mediated transfection. To fuse or not to fuse: is that the question? -","volume":"189","author":"Zuhorn","year":"2002","journal-title":"J. Membr. Biol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2006.04.009","article-title":"Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability","volume":"113","author":"Dass","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jgm.1006","article-title":"siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing","volume":"9","author":"Cardoso","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2008.08.014","article-title":"Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS","volume":"132","author":"Cardoso","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0215","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jconrel.2009.11.004","article-title":"Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo","volume":"142","author":"Cardoso","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.gt.3300821","article-title":"Stabilized plasmid-lipid particles: construction and characterization","volume":"6","author":"Wheeler","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.cgt.7700326","article-title":"Encapsulation of cmyc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line","volume":"8","author":"Leonetti","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejpb.2008.09.026","article-title":"Multifunctional and stimuli-sensitive pharmaceutical nanocarriers","volume":"71","author":"Torchilin","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0235","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1208\/aapsj0902015","article-title":"Targeted pharmaceutical nanocarriers for cancer therapy and imaging","volume":"9","author":"Torchilin","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0240","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0022-3565(24)29491-X","article-title":"Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles","volume":"298","author":"Mui","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/bc050052j","article-title":"Methods for the preparation of protein-oligonucleotide-lipid constructs","volume":"17","author":"Takasaki","year":"2006","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/bc9004365","article-title":"Pedroso de Lima M.C., Simoes S Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment","volume":"21","author":"Mendonca","year":"2010","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbamem.2009.12.001","article-title":"Design of peptide-targeted liposomes containing nucleic acids","volume":"1798","author":"Santos","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0265","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0270","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/bi952000v","article-title":"Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine","volume":"35","author":"Holland","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0275","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","article-title":"Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes","volume":"80","author":"Maurer","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0280","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0290","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(03)00032-8","article-title":"Ligand-targeted liposomal anticancer drugs","volume":"42","author":"Sapra","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0295","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0300","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.5.4.371","article-title":"Advances in PEGylation of important biotech molecules: delivery aspects","volume":"5","author":"Ryan","year":"2008","journal-title":"Expert Opin. Drug Delivery"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0310","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.104.078113","article-title":"Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid","volume":"312","author":"Semple","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0320","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0325","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1073\/pnas.0637295100","article-title":"Dealing with iron: common structural principles in proteins that transport iron and heme","volume":"100","author":"Baker","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0330","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc903","article-title":"Ligand-targeted therapeutics in anticancer therapy","volume":"2","author":"Allen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0335","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.20098","article-title":"Current methods for attaching targeting ligands to liposomes and nanoparticles","volume":"93","author":"Nobs","year":"2004","journal-title":"J. Pharm. Sci"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0340","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-5793(96)00452-8","article-title":"Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time","volume":"386","author":"Uster","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0345","first-page":"889","article-title":"Use of the post-insertion method for the formation of ligand-coupled liposomes","volume":"7","author":"Allen","year":"2002","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","article-title":"A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs","volume":"460","author":"Ishida","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0355","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/08982109909035550","article-title":"Liposomal anticancer drugs as agents to be used in combination with other anticancer agents: studies on a liposomal formulation with two encapsulated drugs","volume":"9","author":"Saxon","year":"1999","journal-title":"J. Liposome Res."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1040-8428(00)00110-4","article-title":"In vitro preclinical models for a rational design of chemotherapy combinations in human tumors","volume":"37","author":"Zoli","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0365","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discovery Today"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0370","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-4157(97)00006-3","article-title":"Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles","volume":"1331","author":"Cullis","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0375","first-page":"2315","article-title":"Concepts of synergism and antagonism","volume":"14","author":"Merlin","year":"1994","journal-title":"Anticancer Res."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0380","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tiv.2007.03.003","article-title":"A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model","volume":"21","author":"Goldoni","year":"2007","journal-title":"Toxicol. In vitro"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0390","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0395","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1021\/nn2013707","article-title":"Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin","volume":"5","author":"Xiong","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0400","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/bit.22858","article-title":"Coencapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrin receptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatment","volume":"107","author":"Mendonca","year":"2010","journal-title":"Biotechnol. Bioeng"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0405","first-page":"1285","article-title":"Oncolytic adenovirus mediated Survivin RNA interference and 5-fluorouracil synergistically suppress the lymphatic metastasis of colorectal cancer","volume":"24","author":"Shen","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0410","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bbamem.2006.11.014","article-title":"Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo","volume":"1768","author":"Tardi","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S1773-2247(12)50006-7_bb0415","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1535-7163.MCT-06-0118","article-title":"Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice","volume":"5","author":"Mayer","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejps.2008.05.006","article-title":"Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release","volume":"34","author":"Li","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0425","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.CCR-1131-03","article-title":"In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading","volume":"10","author":"Abraham","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S1773-2247(12)50006-7_bb0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0005-2736(86)90105-7","article-title":"Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient","volume":"857","author":"Mayer","year":"1986","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Journal of Drug Delivery Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224712500067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224712500067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:06:00Z","timestamp":1761710760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224712500067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1773224712500067"],"URL":"https:\/\/doi.org\/10.1016\/s1773-2247(12)50006-7","relation":{},"ISSN":["1773-2247"],"issn-type":[{"type":"print","value":"1773-2247"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted lipid-based systems for siRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Drug Delivery Science and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1773-2247(12)50006-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}